Product Reports Resources Pricing Login Book a demo

Laurus Labs

Biotech & Life Sciences · Hyderabad, India · Founded 2005 · IPO 2016

An innovation-driven¸ people-centric & client-focused organization offering a broad and integrated portfolio of products & services to the global pharmaceutical industry

Valuation $14B
Revenue $913M
EBITDA $249M

Investors

3 investors on Laurus Labs's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage
Series B+ 1 investor entered at this stage

Global footprint

Where Laurus Labs has talent and traffic

Workforce by country
9 countries with
team presence
🇮🇳 India98.8%
🇺🇸 United States0.5%
🇬🇧 United Kingdom0.2%
🇩🇪 Germany0.1%
🇸🇬 Singapore0.1%
Top 5 of 9 shown
Web traffic by country
19K monthly visits
across markets
🇮🇳 India78.4%
🇺🇸 United States14.2%
🇬🇧 United Kingdom6.8%
🇭🇰 Hong Kong1.1%
Top 4 markets shown

Talent graph

The shape of Laurus Labs's talent

Dealroom maps Laurus Labs's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Laurus Labs's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Capital deployed

Laurus Labs's 4 investments and acquisitions.

Every disclosed deal where Laurus Labs appeared as a backer or acquirer, 2020–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across Laurus Labs's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Laurus Labs's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        What the market is saying about Laurus Labs

        An AI-synthesized read of the highest-engagement posts about Laurus Labs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Laurus Labs on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.